603716
vs
GILD
603716
GILD
Over the past 12 months, Thalys Medical Technology Group Inc has significantly outperformed GILD, delivering a return of +151% compared to the GILD's +34% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
603716
GILD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Intrinsic Value
12.03
CNY
Overvaluation 50%
GILD
Intrinsic Value
116.39
USD
Overvaluation 17%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Thalys Medical Technology Group Inc
SSE:603716
|
24.1
CNY
|
|||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
139.77
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
603716, GILD
603716, GILD
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Thalys Medical Technology Group Inc
Revenue
|
|||||||||||
|
|
Gilead Sciences Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
603716, GILD
603716, GILD
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Thalys Medical Technology Group Inc
SSE:603716
|
|||||||||
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Thalys Medical Technology Group Inc
18.3%
GILD
78.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
Operating Margin
Thalys Medical Technology Group Inc
-8.9%
GILD
40%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
Net Margin
Thalys Medical Technology Group Inc
-19.3%
GILD
28.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
FCF Margin
Thalys Medical Technology Group Inc
4.8%
GILD
32.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
ROE
Thalys Medical Technology Group Inc
-22.3%
GILD
40.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
ROA
Thalys Medical Technology Group Inc
-9.2%
GILD
14.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
ROIC
Thalys Medical Technology Group Inc
-7.8%
GILD
21.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
ROCE
Thalys Medical Technology Group Inc
-7.8%
GILD
25%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Thalys Medical Technology Group Inc | ||||
|
|
Gilead Sciences Inc | ||||
Solvency Comparison
Thalys Medical Technology Group...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
603716, GILD
603716, GILD
Performance Gap
603716, GILD
603716, GILD
Performance By Year
603716, GILD
603716, GILD
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 603716 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Thalys Medical Technology Grou...
ABBV
Abbvie Inc
Cheaper
vs Thalys Medical Technology Grou...
AMGN
Amgen Inc
Cheaper
vs Thalys Medical Technology Grou...
VRTX
Vertex Pharmaceuticals Inc
Cheaper
vs Thalys Medical Technology Grou...
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
